Risk factors of hepatic dysfunction in patients with Graves' hyperthyroidism and the efficacy of 131iodine treatment.

MLA

Renfei Wang, et al. “Risk Factors of Hepatic Dysfunction in Patients with Graves’ Hyperthyroidism and the Efficacy of 131iodine Treatment.” Medicine, vol. 96, no. 5, Feb. 2017, pp. 1–5. EBSCOhost, https://doi.org/10.1097/MD.0000000000006035.

APA

Renfei Wang, Jian Tan, Guizhi Zhang, Wei Zheng, Chengxia Li, Wang, R., Tan, J., Zhang, G., Zheng, W., & Li, C. (2017). Risk factors of hepatic dysfunction in patients with Graves’ hyperthyroidism and the efficacy of 131iodine treatment. Medicine, 96(5), 1–5. https://doi.org/10.1097/MD.0000000000006035

Chicago

Renfei Wang, Jian Tan, Guizhi Zhang, Wei Zheng, Chengxia Li, Renfei Wang, Jian Tan, Guizhi Zhang, Wei Zheng, and Chengxia Li. 2017. “Risk Factors of Hepatic Dysfunction in Patients with Graves’ Hyperthyroidism and the Efficacy of 131iodine Treatment.” Medicine 96 (5): 1–5. doi:10.1097/MD.0000000000006035.